Startseite › Krebs (alle Arten) › Texas › Houston
Klinische Studien zu Krebs (alle Arten) in Houston, TX
121 Studien zu Krebs (alle Arten) suchen Teilnehmer an Standorten in und um Houston (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Teilnehmer gesuchtPhase 1
- The University of Texas - MD Anderson Cancer Center, Houston
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Teilnehmer gesuchtBeobachtungsstudie
- The University of Texas M.D. Anderson Cancer Center, Houston
A Study of PHN-012 in Patients With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- PHN-012-001 Site, Houston
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
Teilnehmer gesuchtPhase 1
- MD Anderson Cancer Center, Houston
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Teilnehmer gesuchtPhase 3
- Investigative Site, Houston
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Teilnehmer gesuchtPhase 3
- Oncology Consultants PA, Houston
- University of Texas MD Anderson Cancer Center, Houston
A Study of JNJ-1761981 in Participants With Solid Tumors
Teilnehmer gesuchtPhase 1
- MD Anderson Cancer Center, Houston
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
Teilnehmer gesuchtPhase 2
- Baylor College of Medicine Medical Center ( Site 0004), Houston
- Harris Health System ( Site 0040), Houston
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Teilnehmer gesuchtPhase 2/3
- Houston Methodist Hospital, Houston
A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- MD Anderson Cancer Center, Houston
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
Teilnehmer gesuchtPhase 1
- MD Anderson Cancer Center, Houston
- NEXT Oncology, Houston
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
Teilnehmer gesuchtPhase 1/2
- University of Texas M.D. Anderson Cancer Center ( Site 4007), Houston
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
Teilnehmer gesuchtPhase 1
- MD Anderson Cancer Center, Houston
Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life
Teilnehmer gesucht
- The University of Texas M. D. Anderson Cancer Center, Houston
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Teilnehmer gesuchtPhase 3
- Houston Methodist Cancer Center, Houston
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Teilnehmer gesuchtPhase 3
- Quetzal Site 6, Houston
Intratumoral N17350 in Advanced Solid Tumors
Teilnehmer gesuchtPhase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Teilnehmer gesuchtPhase 3
- The University of Texas MD Anderson Cancer Center /ID# 280070, Houston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Teilnehmer gesuchtPhase 1/2
- MD Anderson, Houston
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Teilnehmer gesuchtPhase 2
- The University of Texas MD Anderson Cancer Center, Houston
Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions
Teilnehmer gesuchtBeobachtungsstudie
- UT MD Anderson Cancer Center, Houston
Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers.
Teilnehmer gesuchtBeobachtungsstudie
- M D Anderson Cancer Center, Houston
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Teilnehmer gesuchtPhase 2/3
- The University of Texas Health Science Center at Houston, Houston
- University of Texas- MD Anderson, Houston
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
Teilnehmer gesuchtPhase 1/2
- University of Texas-MD Anderson Cancer Center ( Site 3007), Houston
Statins to Prevent Cancer Associated Blood Clots
Teilnehmer gesuchtPhase 4
- The University of Texas MD Anderson Cancer Center, Houston
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Teilnehmer gesuchtPhase 2
- The University of Texas MD Anderson Cancer Center, Houston
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
Teilnehmer gesuchtPhase 2
- The University of Texas M. D. Anderson Cancer Center, Houston
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Teilnehmer gesuchtPhase 1/2
- Research Site, Houston
A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)
Teilnehmer gesuchtPhase 1
- Houston Methodist Hospital ( Site 0103), Houston
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
Teilnehmer gesuchtPhase 1/2
- The University of Texas Md Anderson Cancer Center, Houston
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
Teilnehmer gesuchtPhase 1/2
- NEXT Oncology ( Site 1011), Houston
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Teilnehmer gesuchtPhase 1
- Investigational Site Number: 401, Houston
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Teilnehmer gesuchtPhase 1
- MD Anderson Cancer Center - University of Texas, Houston
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- UT MD Anderson, Houston
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
Teilnehmer gesuchtPhase 1/2
- University of Texas MD Anderson Cancer Center, Houston
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Teilnehmer gesuchtPhase 3
- Houston Methodist Hospital, Houston
- University of Texas MD Anderson Cancer Center, Houston
- Lumi Research, Houston
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Teilnehmer gesuchtPhase 1
- MD Anderson Cancer Center, Houston
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
Teilnehmer gesuchtPhase 2
- M D Anderson Cancer Center, Houston
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Teilnehmer gesuchtPhase 2
- Kelsey-Seybold Clinic, Houston
A Prospective Single Center, Single Arm, Single-institution Registry That Aims to Assess the Safety and Quality of Life Benefits of Computer-assisted Vacuum Thrombectomy (CAVT) in the Treatment of Cancer Patients With Intermediate Risk Pulmonary Embolism (PE)
Teilnehmer gesucht
- The University of Texas M. D. Anderson Cancer Center, Houston
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1
- The University of Texas MD Anderson Cancer Center, Houston
PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System
Teilnehmer gesucht
- The University of Texas M. D. Anderson Cancer Center, Houston
Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma
Teilnehmer gesuchtPhase 2
- M D Anderson Cancer Center, Houston
ORB-021 In Patients With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- MDAC, Houston
Project: Every Child for Younger Patients With Cancer
Teilnehmer gesuchtBeobachtungsstudie
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- UT MD Anderson Cancer Center, Houston
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
Teilnehmer gesuchtPhase 3
- Houston Metro Urology, Houston
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Teilnehmer gesuchtPhase 3
- MD Anderson Cancer Center, Houston
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Psycho-Spiritual Management for Patients With Advanced Cancer and Their Family Caregivers
Teilnehmer gesucht
- MD Anderson, Houston
Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients With Advanced Cancer
Teilnehmer gesuchtBeobachtungsstudie
- The University of Texas M. D. Anderson Cancer Center, Houston
Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms
Teilnehmer gesuchtPhase 1
- The University of Texas M. D. Anderson Cancer Center, Houston
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
Teilnehmer gesuchtPhase 2
- The University of Texas M. D. Anderson Cancer Center, Houston
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
Teilnehmer gesucht
- The University of Texas M. D. Anderson Cancer Center, Houston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1/2
- The University of Texas, MD Anderson Cancer Center, Houston
Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study
Teilnehmer gesuchtPhase 2
- M D Anderson Cancer Center, Houston
Examining the Feasibility and Impact of a Clinic-based Food Farmacy and Digital Culinary Medicine Program Among Cancer Survivors Treated in a Safety Net Hospital
Teilnehmer gesucht
- The University of Texas M. D. Anderson Cancer Center, Houston
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Teilnehmer gesuchtPhase 2
- Texas Childrens Hospital, Houston
- University of Texas MD Anderson Cancer Center, Houston
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Teilnehmer gesuchtPhase 3
- Houston Methodist Hospital, Houston
- Memorial Hermann Texas Medical Center, Houston
- Methodist Willowbrook Hospital, Houston
- und 1 weitere
IDOV-Immune for Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- MD Anderson Cancer Center, Houston
New Assessment System in Measuring Symptom Distress in Cancer Patients
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- M D Anderson Cancer Center, Houston
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
Teilnehmer gesuchtPhase 2
- MD Anderson Cancer Center, Houston
Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer
Teilnehmer gesuchtGesunde Freiwillige willkommen
- MD Anderson Cancer Center, Houston
Decoupling Immunotherapy Toxicity and Cancer Response
Teilnehmer gesuchtBeobachtungsstudie
- The University of Texas M. D. Anderson Cancer Center, Houston
A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients
Teilnehmer gesuchtPhase 3
- M D Anderson Cancer Center, Houston
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
Teilnehmer gesucht
- M D Anderson Cancer Center, Houston
Long-Term Follow-Up of Recipient of Gene Transfer Research
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- University of Texas MD Anderson Cancer Center, Houston
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Teilnehmer gesuchtPhase 1
- Oncology Consultants /ID# 268323, Houston
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Teilnehmer gesuchtPhase 2
- The University of Texas MD Anderson Cancer Center /ID# 273539, Houston
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1/2
- University of Texas MD Anderson Cancer Center, Houston
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
Teilnehmer gesuchtPhase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Teilnehmer gesuchtPhase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Molecular Genetics Studies of Cancer Patients and Their Relatives
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
A Multi Center Study of Sexual Toxicities After Radiotherapy
Teilnehmer gesuchtBeobachtungsstudie
- M.D. Anderson Cancer Center, Houston
Childhood Cancer Survivor Study
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- M.D. Anderson Cancer Center, Houston
- Texas Children's Hospital, Houston
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Teilnehmer gesucht
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Teilnehmer gesuchtPhase 1
- Research Site, Houston
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Teilnehmer gesuchtPhase 2/3
- The University of Texas MD Anderson Cancer Center /ID# 275107, Houston
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Teilnehmer gesuchtPhase 1
- University of Texas MD Anderson Cancer Center /ID# 252004, Houston
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
Teilnehmer gesuchtPhase 1
- The University of Texas MD Anderson Cancer Center, Houston
Active Living After Cancer: Implementation Within Be Well Acres Homes
Teilnehmer gesucht
- The University of Texas M. D. Anderson Cancer Center, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Teilnehmer gesuchtPhase 1/2
- MD Anderson Cancer Center, Houston
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Teilnehmer gesuchtPhase 1/2
- University of Texas MD Anderson Cancer Center, Houston
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- MDACC, Houston
Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial Carcinoma
Teilnehmer gesuchtPhase 1/2
- M D Anderson Cancer Center, Houston
Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers
Teilnehmer gesuchtPhase 2/3
- MD Anderson Cancer Centerr, Houston
A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients
Teilnehmer gesuchtPhase 2
- The University of Texas MD Anderson Cancer Center, Houston
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Teilnehmer gesuchtPhase 1/2
- MD Anderson Cancer Center, Houston
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
Teilnehmer gesuchtPhase 2
- University of Texas MD Anderson Cancer Center, Houston
Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors
Teilnehmer gesuchtBeobachtungsstudie
- M D Anderson Cancer Center, Houston
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Teilnehmer gesuchtPhase 1
- MD Anderson Cancer Center, Houston
Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic
Teilnehmer gesuchtBeobachtungsstudie
- MD Anderson Cancer Center, Houston
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Teilnehmer gesuchtPhase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- University of Texas MD Anderson Cancer Center, Houston
Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
Teilnehmer gesuchtPhase 2
- M D Anderson Cancer Center, Houston
The Cancer Stage Shifting Initiative: Registry and Biorepository to Research and Address Health Disparities in Cancer Care
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- Grace Clinic, Houston
Suprachoroidal Administration in Subjects With Metastases to the Choroid
Teilnehmer gesuchtPhase 2
- Retina Consultants of Texas, Bellaire · 7 mi entfernt
Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery
Teilnehmer gesuchtPhase 2
- Houston Methodist Neal Cancer Center, Houston
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Teilnehmer gesuchtBeobachtungsstudie
- Md Anderson Cancer Center, Houston
Effectiveness and Performance of an Optical Biopsy Technology for Esophageal Cancer in Brazil and the United States
Teilnehmer gesuchtPhase 2
- Baylor St. Luke's Medical Center, Houston
- Ben Taub Hospital (Harris Health Systems), Houston
Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States
Teilnehmer gesucht
- M D Anderson Cancer Center, Houston
Primary Tumor Research and Outcomes Network
Teilnehmer gesuchtBeobachtungsstudie
- The University of Texas M.D. Anderson Cancer Center, Houston
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Teilnehmer gesucht
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
A Study of YL242 in Subjects With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1/2
- US-203, Houston
Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies
Teilnehmer gesuchtPhase 3
- Houston Methodist Neal Cancer Center, Houston
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
Teilnehmer gesuchtPhase 1
- The University of Texas MD Anderson Cancer Center, Houston
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Teilnehmer gesuchtPhase 2
- MD Anderson Cancer Center, Houston
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
Teilnehmer gesuchtBeobachtungsstudie
- MD Anderson Cancer Center, Houston
- Texas Children's Hospital, Houston
Childhood Cancer Predisposition Study (CCPS)
Teilnehmer gesuchtBeobachtungsstudie
- Baylor College of Medicine, Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Teilnehmer gesuchtBeobachtungsstudie
- Massive Bio SYNERGY-AI site, Houston
A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- Oncology Consultants, P.A., Houston
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
Teilnehmer gesucht
- Baylor College of Medicine- McNair Campus, Houston
- Baylor College of Medicine, Houston
- Ben Taub General Hospital, Houston
- und 1 weitere
Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma
Teilnehmer gesuchtPhase 2
- The University of Texas Health Science Center at Houston, Houston
A Study of NX-1607 in Adults With Advanced Malignancies
Teilnehmer gesuchtPhase 1
- MD Anderson Cancer Center, Houston
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1/2
- MD Anderson Cancer Center, Houston
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Teilnehmer gesuchtPhase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Trial of DFP-14927 in Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- MD Anderson Cancer Center, Houston
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Teilnehmer gesuchtPhase 1/2
- Oncology Consultants, P.A., Houston
- The University of Texas M. D. Anderson Cancer Center, Houston
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Teilnehmer gesucht
- The University of Texas MD Anderson Cancer Center, Houston
HPV Vaccine, Imiquimod, and Metformin Combination Trial
Teilnehmer gesuchtPhase 2
- Baylor St. Luke's Medical Center- Dan L. Duncan Comprehensive Cancer Center, Houston
- Harris Health Smith Clinic, Houston
A Study in Patients With Advanced Cancers
Teilnehmer gesuchtPhase 1/2
- University of Texas MD Anderson Cancer Center, Houston
Krebs (alle Arten)-Studien in anderen Städten
- New York City, NY110 Studien
- Boston, MA86 Studien
- Los Angeles, CA73 Studien
- Nashville, TN65 Studien
- Philadelphia, PA59 Studien
- Durham, NC58 Studien
- Washington, DC58 Studien
- Chicago, IL51 Studien
- Seattle, WA49 Studien
- Atlanta, GA49 Studien
- Arlington, VA48 Studien
- St. Louis, MO46 Studien
Weitere Studien in Houston
- Nichtkleinzelliges Lungenkarzinom145 Studien
- Brustkrebs126 Studien
- Metastasierender Krebs104 Studien
- Kolorektales Karzinom102 Studien
- Eierstockkrebs89 Studien
- Akute myeloische Leukämie85 Studien
- Lungenkrebs78 Studien
- Prostatakrebs76 Studien
- Endometriumkarzinom68 Studien
- Bauchspeicheldrüsenkrebs61 Studien
- Melanom59 Studien
- Plattenepithelkarzinom im Kopf-Hals-Bereich47 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 05.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.